-
Mashup Score: 4
This is a Hybrid Course Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer. This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI), MRI-ultrasound fusion biopsy, including…
Source: cpdlearn.massgeneralbrigham.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1722nd Biennial Course in Urologic Oncology - 1 month(s) ago
Beginning in 1982, the multidisciplinary Urologic Cancer Course was designed as a biennial course bringing together expertise from all the Harvard teaching hospitals in conjunction with invited, world-class experts in urologic oncology, medical oncology, and radiation oncology. Dr. Marc B. Garnick led the course from 1982 to 1996 at which time Dr. Jerome P. Richie assumed the leadership until 2014. Dr. Phillip W. Kantoff then led the course and subsequently in 2016 Dr. Adam Kibel, Dr. Toni Choueiri, and Dr. Anthony V D’Amico co-led the course.Who Should AttendPhysician AssistantsNurse PractitionersPrimary Care PhysiciansSpecialty PhysiciansNursesResidents and FellowsOtherLearning ObjectivesUpon completion of this activity, participants will be able to:Demonstrate the optimal management of oligometastatic prostate, bladder, and renal cancer.Explain the role of immunotherapy in the management of bladder, prostate, and renal cancer.Determine how to incorporate genomic classifiers, multipl
Source: cmecatalog.hms.harvard.eduCategories: General Medicine News, Hem/OncsTweet-
Busy few weeks ahead!! Besides ⬇️, the @PCFnews @PCF_Science, and the MGB Rad Onc Retreat, also great opportunities to brush up on the latest in urologic oncology cancers (https://t.co/BinmdQtUXM) as well as imaging for prostate cancer (https://t.co/qc6Pn7VZul) Register today! https://t.co/Vdi73vXecJ
-
-
Mashup Score: 38
PURPOSEThe value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncological outcomes between bladder-only (BO)-RT and whole-…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
RT @gautiermarcq: Just in 👉 @JCO_ASCO Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC https://t.co/uY8XqgrCF8 👇👇👇TWEETOR…
-
-
Mashup Score: 38
PURPOSEThe value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncological outcomes between bladder-only (BO)-RT and whole-…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
RT @gautiermarcq: Just in 👉 @JCO_ASCO Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC https://t.co/uY8XqgrCF8 👇👇👇TWEETOR…
-
-
Mashup Score: 38
PURPOSEThe value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncological outcomes between bladder-only (BO)-RT and whole-…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
RT @gautiermarcq: Just in 👉 @JCO_ASCO Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC https://t.co/uY8XqgrCF8 👇👇👇TWEETOR…
-
-
Mashup Score: 36
PURPOSEThe value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncological outcomes between bladder-only (BO)-RT and whole-…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
RT @gautiermarcq: Just in 👉 @JCO_ASCO Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC https://t.co/uY8XqgrCF8 👇👇👇TWEETOR…
-
-
Mashup Score: 5Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care - 2 month(s) ago
Prostate Cancer and Prostatic Diseases – Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care
Source: www.nature.comCategories: General Medicine News, Oncologists1Tweet-
Dr Curt Deville also sets the stage by discussing the historical timeline of protons for prostate cancer, also reviewing older studies evaluating photons vs protons, highlighting our review https://t.co/i8DPsqBRvW https://t.co/p30DcIjLov
-
-
Mashup Score: 11Hear From Your Peers on Why You Should Submit to ASCO #GU25 - 2 month(s) ago
For more information, visit https://conferences.asco.org/gu/abstract-submission
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
🚨ATTENTION GU Oncology physicians, researchers, patient advocates, fellows, trainees, students, and all others!!🚨 SUBMIT an abstract for the upcoming #GU25 ASCO GU Cancers Symposium DEADLINE: October 15 2024. Check out 👇 the following! @ASCO https://t.co/IsGxbnaCcD
-
-
Mashup Score: 4Genomic Tumor Correlates of Response to Trimodal Therapy for Muscle-Invasive Bladder Cancer - Sophia Kamran - 6 month(s) ago
Sam Chang hosts Sophia Kamran to discuss her recent research on bladder cancer. The study, titled “Genomic Tumor Correlates of Clinical Outcomes Following Organ-sparing Chemoradiation Therapy for Bladder Cancer,” focuses on genomic characterizations that could predict outcomes for bladder preservation strategies. Dr. Kamran details the use of genomic and transcriptomic profiling to guide…
Source: www.urotoday.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/0hb1OExVNV via @urotoday
-
-
Mashup Score: 9Advancements in Treating Early-Stage Biochemical Recurrence in Hormone-Sensitive Prostate Cancer - 7 month(s) ago
I’m moderating a small group on Gather-ed, a social learning platform. The curriculum focuses on providing care to patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC). Free CME credit is being offered. Please join!
Source: medicallogix.gathered.comCategories: General Medicine News, Hem/OncsTweet-
Advancements in Treating Early-Stage Biochemical Recurrence in Hormone-Sensitive Prostate Cancer https://t.co/IOdzuQzp9k Sign up and join me at Gather-ED to learn more. Free CME!!
-
RT @MassGenBrighCPD: Don't miss @MGHCancerCenter's CME course on FRIDAY! https://t.co/FHuqg9RqNe @AFeldmanMD @mharisinghani https://t.co/Z6…